• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃癌根治性手术:166例连续病例研究

Curative surgery for gastric cancer: study of 166 consecutive patients.

作者信息

de Almeida J C, Bettencourt A, Costa C S, de Almeida J M

机构信息

Department of Surgery, Instituto Português de Oncologia de Francisco Gentil, Centro de Lisboa, Clínica Oncológica III, Lisbon, Portugal.

出版信息

World J Surg. 1994 Nov-Dec;18(6):889-94; discussion 894-5. doi: 10.1007/BF00299097.

DOI:10.1007/BF00299097
PMID:7846914
Abstract

From January 1980 to December 1991 we operated on 295 patients with a gastric carcinoma. In 166 cases (56.3%) surgery was performed with curative intent. In 93 patients (56%) a subtotal gastrectomy was performed, and in 73 cases (44%) a total gastrectomy. In all the cases a D-2 type lymphadenectomy was used. The global morbidity rate was 23%, and in-hospital mortality was 3.6%. The morbidity and mortality rates of these two operations were statistically different. Global 5-year survival estimate for the whole series is 61.3%. Univariate and multivariate analysis according to T and N (TNM classification), the number of positive nodes resected, and the relation of positive per resected nodes, revealed statistically different outcomes. This kind of quantitative classification allowed identification of high risk groups irrespective of site of nodal involvement. Tumors classified as intestinal or diffuse type by the Lauren classification had similar survival curves and 5-year survival estimates (p = 0.834). By univariate and multivariate analysis this classification did not reveal a prognostic value in this group of patients. In our opinion, tumor penetration and lymph node involvement are at present the most reliable prognostic factors available.

摘要

1980年1月至1991年12月,我们对295例胃癌患者进行了手术。其中166例(56.3%)进行了根治性手术。93例(56%)患者接受了胃大部切除术,73例(44%)接受了全胃切除术。所有病例均采用D-2型淋巴结清扫术。总体发病率为23%,住院死亡率为3.6%。这两种手术的发病率和死亡率在统计学上存在差异。整个系列的总体5年生存率估计为61.3%。根据T和N(TNM分类)、切除的阳性淋巴结数量以及每切除淋巴结中的阳性淋巴结关系进行单因素和多因素分析,结果显示预后存在统计学差异。这种定量分类能够识别高危组,而不考虑淋巴结受累部位。根据劳伦分类法分为肠型或弥漫型的肿瘤具有相似的生存曲线和5年生存率估计(p = 0.834)。通过单因素和多因素分析,该分类在这组患者中未显示出预后价值。我们认为,肿瘤浸润深度和淋巴结受累情况是目前最可靠的预后因素。

相似文献

1
Curative surgery for gastric cancer: study of 166 consecutive patients.胃癌根治性手术:166例连续病例研究
World J Surg. 1994 Nov-Dec;18(6):889-94; discussion 894-5. doi: 10.1007/BF00299097.
2
A prospective study of gastric cancer. 'Real' 5-year survival rates and mortality rates in a country with high incidence.一项关于胃癌的前瞻性研究。一个高发病率国家的“真实”5年生存率和死亡率。
Dig Surg. 1998;15(4):317-22. doi: 10.1159/000018645.
3
[Prognostic factors in resected stomach carcinoma].[根治性切除胃癌的预后因素]
Schweiz Med Wochenschr. 1994 Jun 4;124(22):945-52.
4
Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.无论检查的淋巴结数量多少,淋巴结比率都是可切除(R0)胃癌患者的独立预后因素。
Am J Clin Oncol. 2013 Aug;36(4):325-30. doi: 10.1097/COC.0b013e318246b4e9.
5
What is the role of nodal ratio as a prognostic factor for gastric cancer nowadays? Comparison with new TNM staging system and analysis according to the number of resected nodes.目前,淋巴结比率作为胃癌预后因素的作用是什么?与新的TNM分期系统的比较以及根据切除淋巴结数量进行的分析。
Am Surg. 2013 May;79(5):483-91.
6
[Results following resection in early stomach carcinoma].
Dtsch Med Wochenschr. 1994 Apr 15;119(15):539-43. doi: 10.1055/s-2008-1058727.
7
[Total gastrectomy for gastric cancer: can the type of lymphadenectomy condition the long-term results?].[胃癌全胃切除术:淋巴结清扫类型会影响长期疗效吗?]
Suppl Tumori. 2005 May-Jun;4(3):S84-5.
8
Stomach cancer: a study of 117 consecutive resected cases and results of R2-R3 gastrectomy.
Int Surg. 1991 Jan-Mar;76(1):23-6.
9
Prognostic significance of metastatic lymph nodes ratio in patients with gastric adenocarcinoma after curative gastrectomy.根治性胃切除术后胃腺癌患者转移淋巴结比率的预后意义
Chin Med J (Engl). 2014;127(10):1874-8.
10
[Clinical value of superior mesenteric vein (No.14v) lymph node dissection in D2 gastrectomy for locally advanced distal gastric cancer].[肠系膜上静脉(第14v组)淋巴结清扫在局部进展期远端胃癌D2根治性胃切除术中的临床价值]
Zhonghua Wei Chang Wai Ke Za Zhi. 2018 Oct 25;21(10):1136-1141.

引用本文的文献

1
A Histopathological and Surgical Analysis of Gastric Cancer: A Two-Year Experience in a Single Center.胃癌的组织病理学与手术分析:单中心两年经验
Cancers (Basel). 2025 Jul 2;17(13):2219. doi: 10.3390/cancers17132219.
2
Clinicopathological analysis of patients with gastric cancer in 1200 cases.1200例胃癌患者的临床病理分析
World J Gastroenterol. 2001 Apr;7(2):281-4. doi: 10.3748/wjg.v7.i2.281.
3
Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group.

本文引用的文献

1
THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION.胃癌的两种主要组织学类型:弥漫型和所谓的肠型癌。组织学临床分类的尝试。
Acta Pathol Microbiol Scand. 1965;64:31-49. doi: 10.1111/apm.1965.64.1.31.
2
Prognostic factors in gastric carcinoma. Results of the German Gastric Carcinoma Study 1992.胃癌的预后因素。1992年德国胃癌研究结果
Cancer. 1993 Oct 1;72(7):2089-97. doi: 10.1002/1097-0142(19931001)72:7<2089::aid-cncr2820720706>3.0.co;2-h.
3
Selection of operative procedure for adenocarcinoma of the midstomach. Twenty years' experience with implications for future treatment strategy.
胃癌D1和D2切除术后患者的生存率:MRC随机外科试验的长期结果。外科合作组。
Br J Cancer. 1999 Mar;79(9-10):1522-30. doi: 10.1038/sj.bjc.6690243.
胃中部腺癌手术方式的选择。二十年经验及对未来治疗策略的启示。
Ann Surg. 1980 Dec;192(6):730-7. doi: 10.1097/00000658-198012000-00007.
4
The general rules for the gastric cancer study in surgery and pathology. Part I. Clinical classification.胃癌外科与病理学研究的一般规则。第一部分。临床分类。
Jpn J Surg. 1981 Mar;11(2):127-39. doi: 10.1007/BF02468883.
5
Adequacy of margins of resection in gastrectomy for cancer.胃癌胃切除术中切缘的充分性
Ann Surg. 1982 Dec;196(6):685-90. doi: 10.1097/00000658-198212001-00012.
6
R2/3 gastrectomy for gastric carcinoma: an audited experience of a consecutive series.
Br J Surg. 1985 Feb;72(2):146-8. doi: 10.1002/bjs.1800720226.
7
Subtotal versus total gastrectomy for cancer of the lower two-thirds of the stomach: a new approach to an old problem.胃下三分之二癌症的次全胃切除术与全胃切除术:解决老问题的新方法。
Br J Surg. 1986 Jul;73(7):534-8. doi: 10.1002/bjs.1800730706.
8
Node dissection in gastric cancer.胃癌中的淋巴结清扫术
Br J Surg. 1987 Sep;74(9):770-3. doi: 10.1002/bjs.1800740904.
9
Results of gastric resection for carcinoma of the stomach: the European experience.胃癌胃切除术的结果:欧洲经验。
World J Surg. 1988 Jun;12(3):374-81. doi: 10.1007/BF01655678.
10
Lymphadenectomy for cure in patients with early gastric cancer and lymph node metastasis.早期胃癌伴淋巴结转移患者的根治性淋巴结清扫术。
Am J Surg. 1988 Mar;155(3):476-80. doi: 10.1016/s0002-9610(88)80116-8.